Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study.
暂无分享,去创建一个
J. Patard | J. Lam | R. Figlin | A. Belldegrun | D. Chopin | C. Wood | A. Zisman | A. Pantuck | C. Dinney | C. Abbou | A. De la taille | P. Mulders | V. Ficarra | L. Cindolo | W. Artibani | F. Dorey | J. Tostain | Ken‐ryu Han | Hyung L. Kim | D. Swanson | B. Lobel
[1] R. Figlin,et al. Validation of an integrated staging system toward improved prognostication of patients with localized renal cell carcinoma in an international population. , 2003, The Journal of urology.
[2] S. Steinberg,et al. Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] Maamoun M Al-Aynati,et al. Interobserver and intraobserver variability using the Fuhrman grading system for renal cell carcinoma. , 2003, Archives of pathology & laboratory medicine.
[4] J. Folkman. Role of angiogenesis in tumor growth and metastasis. , 2002, Seminars in oncology.
[5] J. Cheville,et al. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. , 2002, The Journal of urology.
[6] R. Figlin,et al. Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] R. Motzer,et al. Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] A. Belldegrun,et al. The changing natural history of renal cell carcinoma. , 2001, The Journal of urology.
[9] M. Kattan,et al. A postoperative prognostic nomogram for renal cell carcinoma. , 2001, The Journal of urology.
[10] R. Figlin,et al. Improved prognostication of renal cell carcinoma using an integrated staging system. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] M Mazumdar,et al. Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] Holger Moch,et al. The Heidelberg classification of renal cell tumours , 1997, The Journal of pathology.
[13] L. Sobin,et al. TNM staging of renal cell carcinoma , 1997, Cancer.
[14] L. Sobin,et al. Union Internationale Contre le Cancer (UICC) and the American Joint TNM Staging of Renal Cell Committee on Cancer (AJCC) Carcinoma , 1997 .
[15] D. Trump,et al. Prognostic factors for survival in patients with recurrent or metastatic renal cell carcinoma. , 1988, Cancer research.
[16] E. McFadden,et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group , 1982, American journal of clinical oncology.
[17] S. Fuhrman,et al. Prognostic significance of morphologic parameters in renal cell carcinoma , 1982, The American journal of surgical pathology.